Constitutive bone marrow adipocytes suppress local bone formation.

Bone marrow adipocytes have traditionally been viewed as inert space-fillers in bone cavities. However, recent studies suggest they may influence hematopoiesis and bone metabolism. Prior research has shown that marrow adipocytes coexist with bone-forming cells, but their exact roles remain unclear. This gap motivated the need for models that can specifically target bone marrow adipocytes without affecting other cell types. Existing methods often fail to distinguish marrow adipocytes from other stromal cells. As a result, findings may be confounded by unintended effects on non-target cells. This uncertainty drove the development of new tools to study marrow adipocytes independently. No prior work had resolved how marrow adipocytes interact with bone formation processes. Understanding these interactions could clarify whether marrow adipocytes suppress or support bone growth.

The aim of this study was to investigate the role of bone marrow adipocytes in bone formation. Researchers wanted to determine if marrow adipocytes may suppress local bone growth. They sought to develop a specific mouse model to target marrow adipocytes without affecting other cell types. The motivation was to address limitations in current models that include non-marrow adipocytes or stromal cells. By isolating marrow adipocytes, they could better assess their physiological effects. The study also aimed to test whether reducing marrow adipocytes could increase bone mass. Researchers were particularly interested in whether this effect would protect against bone loss from dietary or hormonal changes. The goal was to clarify the direct impact of marrow adipocytes on bone metabolism.

The study used a Cre-loxP system to generate a mouse model that allows specific targeting of bone marrow adipocytes. The model was designed to express diphtheria toxin A (DTA) or delete Pparg in marrow adipocytes. This approach enabled researchers to selectively deplete marrow adipocytes without affecting other cell types. Bone mass and hematopoietic cell numbers were measured in mice with and without marrow adipocyte depletion. Bone formation was assessed using histological and micro-CT techniques. Researchers also tested the effects of marrow adipocyte depletion on bone loss caused by caloric restriction or ovariectomy. Fracture healing was evaluated to determine if marrow adipocyte depletion accelerates bone repair. The Pparg deletion model was used to confirm whether Pparg is necessary for marrow adipocyte function.

Mice with DTA-induced marrow adipocyte depletion showed increased bone mass in the distal tibiae and caudal vertebrae. Bone formation was enhanced at endosteal surfaces, suggesting a local effect from marrow adipocyte depletion. Hematopoietic stem and progenitor cell numbers were reduced in these mice. Bone mass gains were observed even under conditions of caloric restriction or ovariectomy. Mice with marrow adipocyte depletion showed improved bone healing after fractures. Pparg deletion in marrow adipocytes also reduced their numbers and increased bone mass. These findings suggest that marrow adipocyte depletion may enhance bone formation. The results indicate that marrow adipocytes may suppress local bone growth.

The findings suggest that marrow adipocytes may suppress local bone formation. Depletion of marrow adipocytes leads to increased bone mass in specific regions. Enhanced bone formation appears to be a direct effect of marrow adipocyte depletion. The results indicate that marrow adipocytes may negatively influence hematopoiesis. Mice with marrow adipocyte depletion were protected from bone loss caused by caloric restriction or ovariectomy. Pparg deletion in marrow adipocytes produced similar effects to DTA-induced depletion. These findings support the idea that marrow adipocytes may suppress bone growth. The study highlights the need for models that can specifically target marrow adipocytes.